{
    "doi": "https://doi.org/10.1182/blood.V112.11.2430.2430",
    "start_url": "https://ashpublications.org/blood/search-results?sort=Date+-+Oldest+First&f_ArticleTypeDisplayName=Meeting+Report&fl_SiteID=1000001&page=1237",
    "start_url_page_num": 1237,
    "is_scraped": "1",
    "article_title": "Functional analysis of the Human Pbx Interacting Protein (HPIP) in Human Hematopoiesis ",
    "article_date": "November 16, 2008",
    "session_type": "Hematopoiesis - Regulation of Gene Transcription",
    "topics": [
        "acute lymphocytic leukemia",
        "amino acids",
        "binding (molecular function)",
        "cd34 antigens",
        "cytoplasm",
        "cytoskeleton",
        "dna, complementary",
        "granulocytes",
        "hematopoiesis",
        "hematopoietic stem cells"
    ],
    "author_names": [
        "Pawandeep Kaur, M.Sc(Hons)",
        "Christiane Stadler, PhD",
        "Farid Ahmed, PhD",
        "Monica Cusan, MTA",
        "R. Keith Humphries, MD, PhD",
        "Wolfgang Hiddemann, MD",
        "Christian Buske, PD.med",
        "Michaela Feuring-Buske, PD.med"
    ],
    "author_affiliations": [
        [
            "Haematologikum, Klinische Kooperationsgruppe am Ha\u0308matologikum der Helmholtz Zentrum, Medizinische Klinik III, Klinikum der LMU Mu\u0308nchen-Gro\u00dfhade, Muenchen, Germany"
        ],
        [
            "Haematologikum, Klinische Kooperationsgruppe am Ha\u0308matologikum der Helmholtz Zentrum, Medizinische Klinik III, Klinikum der LMU Mu\u0308nchen-Gro\u00dfhade, Muenchen, Germany"
        ],
        [
            "Haematologikum, Klinische Kooperationsgruppe am Ha\u0308matologikum der Helmholtz Zentrum, Medizinische Klinik III, Klinikum der LMU Mu\u0308nchen-Gro\u00dfhade, Muenchen, Germany"
        ],
        [
            "Haematologikum, Klinische Kooperationsgruppe am Ha\u0308matologikum der Helmholtz Zentrum, Medizinische Klinik III, Klinikum der LMU Mu\u0308nchen-Gro\u00dfhade, Muenchen, Germany"
        ],
        [
            "Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada"
        ],
        [
            "Department of Internal Medicine III, University of Munich-Hopsital Gro\u00dfhadern, Munich, Germany"
        ],
        [
            "Haematologikum, Klinische Kooperationsgruppe am Ha\u0308matologikum der Helmholtz Zentrum, Medizinische Klinik III, Klinikum der LMU Mu\u0308nchen-Gro\u00dfhade, Muenchen, Germany"
        ],
        [
            "Haematologikum, Klinische Kooperationsgruppe am Ha\u0308matologikum der Helmholtz Zentrum, Medizinische Klinik III, Klinikum der LMU Mu\u0308nchen-Gro\u00dfhade, Muenchen, Germany"
        ]
    ],
    "first_author_latitude": "48.121783549999996",
    "first_author_longitude": "11.515781749999999",
    "abstract_text": "The recognition of novel proteins that regulate human hematopoietic stem cell and early progenitor cell fate is a prime objective in experimental and clinical hematology. Human hematopoietic PBX interacting protein (HPIP), with no significant homology to known proteins, is a 731 amino acid protein, discovered as a novel interacting partner of the PBX homeodomain protein. HPIP has been implicated as a nuclear-cytoplasmic shuttle molecule and shown to have the capacity to bind to the cytoskeleton. It also inhibits the ability of PBX-HOX heterodimers to bind to target sequences and strongly inhibits the transactivation activity of E2A-PBX1 [t(1;19) translocation, which occurs in 25% of pediatric pre-B cell acute lymphocytic leukaemia] (Abramovich C. et al JBC, 2000; Oncogene, 2002). It is highly expressed in human CD34 + progenitor cells, but is silenced in differentiated cells. To gain further insights into the possible functional role of HPIP and its domains and its possible role in a common pathway with HOX transcription co-factor PBX1, HPIP cDNA was cloned in pMSCV-IRES-YFP cassette. Umbilical cord blood enriched with CD34 + population of stem cells was obtained to perform in vitro and in vivo experiments. Mutants, with deletions of the microtubule binding region (\u0394MBR-HPIP), and nuclear receptor and PBX1 interacting motif (\u0394NRPID-HPIP) were generated and tested in vitro and in vivo . The constitutive expression of HPIP wt and \u0394MBR-HPIP in human cord blood cells (CD34 + ) enhanced erythroid colony formation in CFC assay (p=0.008, n=6) while the \u0394NRPID-HPIP mutant nullified the effect. Both mutants of HPIP augmented significantly, the formation of primitive colonies (GEMM and GM) in methylcellulose assay (p\u22640.01, n=6) as compared to YFP control and HPIP wt. In replating CFC assays \u0394NRPID-HPIP showed an increased number of myeloid colonies (p\u22640.01, n=6) and GM (p=ns) colonies but a decrease in granulocytic colonies (p\u22640.05, n=6) compared to YFP control and HPIP wt"
}